GLP-1 receptor agonists have dominated the conversation in diabetes management — but they are not the right fit for every patient. In this session, Dr. Jyothi Joseph-Hayes provides a comprehensive, evidence-based review of the full landscape of Type 2 diabetes medications beyond GLP-1s, including SGLT-2 inhibitors, DPP-4 inhibitors, metformin, sulfonylureas, and newer agents. Dr. Joseph-Hayes will discuss the mechanisms, benefits, risks, and clinical considerations for each medication class, with a focus on individualized treatment decision-making for women at midlife and beyond. Attendees will leave with a clearer framework for selecting the right medication strategy for patients who cannot tolerate, do not respond to, or are not candidates for GLP-1 therapy.

Jyothi Joseph-Hayes, MD, is an accomplished endocrinologist with over 15 years of experience specializing in diabetes, metabolic health, and endocrine disorders. With a strong academic background and a passion for advancing patient care, she combines scientific rigor with a compassionate approach to help individuals achieve optimal health.

Dr. Joseph-Hayes earned her degree in Chemical Engineering with a biochemical emphasis from the University of Missouri-Columbia, then pursued her medical degree at Rush Medical College in Chicago. She completed her residency in Internal Medicine at Rush University Medical Center and her fellowship in Endocrinology, Diabetes, and Metabolism at the University of Michigan, where she honed her expertise in the management of complex endocrine conditions.

Dedicated to ongoing education, Dr. Joseph-Hayes is committed to integrating the latest advancements in endocrinology with individualized, evidence-based care. Her approach emphasizes treating patients within the context of their unique lives, ensuring that each plan is tailored to achieve the best outcomes.